Table 1 Clinical characteristics of all patients (N = 90)
From: Prognostic value of genetic aberrations and tumor immune microenvironment in primary acral melanoma
Characteristics | N (%) |
|---|---|
Age, median (range), year | 62 (38–86) |
Sex | |
 Male | 35 (38.9%) |
 Female | 55 (61.1%) |
Clinical stage | |
 I | 9 (10.0%) |
 II | 41 (45.6%) |
 III | 35 (38.9%) |
 IV | 5 (5.6%) |
Pathological type | |
 NM | 30 (33.3%) |
 ALM | 40 (44.4%) |
 Othersa | 11 (12.2%) |
 Unknown | 9 (10.0%) |
Breslow thickness, mm | |
 ≤ 1.0 | 4 (4.4%) |
 1.01–2.0 | 16 (17.8%) |
 2.01–4.0 | 25 (27.8%) |
 > 4.0 | 37 (41.1%) |
 Unknown | 8 (8.9%) |
Primary site | |
 Hand | 11 (12.2%) |
 Foot | 79 (87.8%) |
Ulceration status | |
 Yes | 56 (62.2%) |
 No | 33 (36.7%) |
 Unknown | 1 (1.1%) |
Treatment | |
 Yes | 66 (73.3%) |
 No | 24 (26.7%) |
Mutation statusb | |
 BRAFm | 12 (14.5%) |
 NRASm | 10 (12.0%) |
 KITm | 14 (16.9%) |
 BRAFw&NRASw&KITw | 44 (53.0%) |
Survival | |
 Alive | 54 (60.0%) |
 Dead | 36 (40.0%) |